시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 크로마틴 면역 침강(ChIP) 시퀀스 시장 보고서(2025년)
Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2025
상품코드 : 1682055
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,253,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,039,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,824,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

크로마틴 면역 침강(ChIP) 시퀀스 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 12.9%로 253억 7,000만 달러로 성장합니다. 예측 기간의 성장은 업계 투자 및 경쟁, 임상 도입 및 진단 용도, 바이오마커 탐색 수요, 생물정보학 툴의 급속한 발전, 신약개발에 대한 적용 확대 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 임상 도입 및 진단 적용, 히스톤 변형에 대한 관심, 새로운 연구 분야로의 적용, 시료 준비의 발전, 멀티오믹스 통합 등이 있습니다.

크로마틴 면역침강(ChIP) 시퀀싱 시장의 성장은 전립선암의 유병률 증가에 의해 주도될 것으로 예상됩니다. ChIP-seq는 질병에 영향을 미치는 분자적 사건에 대한 종합적인 이해를 제공함으로써 전립선암 연구에 중요한 역할을 하고 있으며, 전립선암에 발생하는 전립선암은 시장 확대에 기여할 것으로 예상됩니다. 2023년 1월 미국암협회는 미국내 전립선암 신규 환자 288,300명, 사망자 34,700명(2023년 1월 기준)으로 추산되는 이 건강 문제를 해결하기 위해 ChIP-seq의 중요성이 더욱 커질 것으로 예상하고 있습니다. ChIP-seq의 중요성이 강조되고 있습니다.

크로마틴 면역침강(ChIP) 시퀀싱 시장의 성장은 맞춤형 의료의 채택 증가로 인해 촉진될 것으로 예상됩니다. 맞춤형 의료는 환자 개개인의 특성에 맞게 의료 결정을 내리는 것으로, 질병과 관련된 특정 유전자 및 후성유전학적 마커의 식별에 의존하며, ChIP 시퀀싱은 질병의 유전적 기초를 이해하는 데 중요한 후성유전학적 변형을 매핑하는 강력한 툴로 입증되었습니다. 2022년 FDA의 약물평가연구센터가 37개의 새로운 분자 실체를 승인하고 그 중 34%가 개인맞춤의료연합(Personalized Medicine Coalition)에 의해 맞춤형 의약품으로 지정되었습니다는 사실은 개인맞춤의료의 발전에 ChIP 시퀀싱이의 발전에 있으며, ChIP 시퀀싱의 역할을 강조하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Chromatin immunoprecipitation (ChIP) sequencing is a powerful molecular biology technique employed to investigate the interactions between proteins and DNA within a cell, offering insights into the binding patterns of specific proteins, often transcription factors or other chromatin-associated proteins, to DNA in a genome-wide manner.

The main types of ChIP sequencing include DNase-sequencing and Faire-sequencing. DNase-sequencing, commonly known as DNase-seq, is a molecular biology technique designed to assess the accessibility of DNA within the genome. It utilizes various technologies such as targeted sequencing, re-sequencing, whole genome sequencing, and whole exome sequencing for pre-sequencing, sequencing, and data analysis. The applications of DNase-seq encompass consumables and reagents, services, and other related components. The technique finds usage in academic research institutes, clinical research institutes, hospitals and clinics, pharmaceuticals and biotechnology companies, among others.

The chromatin immunoprecipitation (ChIP) sequencing market research report is one of a series of new reports from The Business Research Company that provides chromatin immunoprecipitation (ChIP) sequencing market statistics, including chromatin immunoprecipitation (ChIP) sequencing industry global market size, regional shares, competitors with a chromatin immunoprecipitation (ChIP) sequencing market share, detailed chromatin immunoprecipitation (ChIP) sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the chromatin immunoprecipitation (ChIP) sequencing industry. This chromatin immunoprecipitation (ChIP) sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chromatin immunoprecipitation (ChIP) sequencing market size has grown rapidly in recent years. It will grow from $13.89 billion in 2024 to $15.6 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to understanding gene regulation, rise in epigenetics studies, data analysis and bioinformatics tools, cost reduction and scalability.

The chromatin immunoprecipitation (ChIP) sequencing market size is expected to see rapid growth in the next few years. It will grow to $25.37 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to industry investment and competition, clinical adoption and diagnostic applications, demand for biomarker discovery, rapid development in bioinformatics tools, expanded applications in drug discovery. Major trends in the forecast period include clinical translation and diagnostic applications, focus on histone modifications, application in novel research areas, advancements in sample preparation, multi-omics integration.

The growth of the chromatin immunoprecipitation (ChIP) sequencing market is expected to be driven by the increasing prevalence of prostate cancer. Prostate cancer, which originates in the prostate gland, is anticipated to contribute to the market's expansion. ChIP-seq plays a vital role in prostate cancer research by providing a comprehensive understanding of the molecular events influencing the disease. This information is crucial for advancing the understanding of its biology and developing more targeted therapeutic interventions. In January 2023, the American Cancer Society reported an estimated 288,300 new cases of prostate cancer and 34,700 deaths in the US, emphasizing the significance of ChIP-seq in addressing this health concern.

The growth of the chromatin immunoprecipitation (ChIP) sequencing market is expected to be propelled by the increasing adoption of personalized medicine. Personalized medicine, which tailors medical decisions to individual patient characteristics, relies on identifying specific genetic or epigenetic markers associated with diseases. ChIP sequencing proves to be a powerful tool in mapping epigenetic modifications crucial for understanding the genetic basis of diseases. In 2022, the approval of 37 novel molecular entities by the FDA's Center for Drug Evaluation and Research, with 34% designated as tailored medications by the Personalized Medicine Coalition, highlights the role of ChIP sequencing in advancing personalized medicine.

Major companies in the chromatin immunoprecipitation (ChIP) sequencing market are concentrating on innovative technologies, such as hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing), to improve the efficiency and accuracy of epigenomic research. This focus is expected to drive advancements in drug discovery and personalized medicine. hmqChIP-seq is an advanced technology aimed at enhancing the study of epigenetic modifications throughout the genome. For instance, in June 2024, Epigenica, a Sweden-based life sciences technology company, launched its EpiFinder Platform, which incorporates patented hmqChIP-seq technology. This platform allows for high-throughput, multiplex quantitative analysis in epigenomic research, enabling researchers to generate 192 genome-wide profiles simultaneously from up to 24 samples. This innovative solution streamlines large-scale experiments with unprecedented speed and cost efficiency.

Major companies operating in the chromatin immunoprecipitation (chip) sequencing market report are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam PLC, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies PLC, Porvair Sciences Ltd., Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.

North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chromatin immunoprecipitation (chip) sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chromatin immunoprecipitation (ChIP) sequencing market consists of revenues earned by entities by providing services such as ChIP sample preparation, library preparation and sequencing, bioinformatics analysis, customization and consultation, data interpretation and reporting, and quality control, and assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. The ChIP sequencing market also includes sales of ChIP kits, antibodies, DNA library preparation kits, sequencing kits, chromatin shearing equipment, and epigenetic modification kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chromatin immunoprecipitation (chip) sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for chromatin immunoprecipitation (chip) sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chromatin immunoprecipitation (chip) sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Chromatin immunoprecipitation (ChIP) Sequencing Market Characteristics

3. Chromatin immunoprecipitation (ChIP) Sequencing Market Trends And Strategies

4. Chromatin immunoprecipitation (ChIP) Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chromatin immunoprecipitation (ChIP) Sequencing Growth Analysis And Strategic Analysis Framework

6. Chromatin immunoprecipitation (ChIP) Sequencing Market Segmentation

7. Chromatin immunoprecipitation (ChIP) Sequencing Market Regional And Country Analysis

8. Asia-Pacific Chromatin immunoprecipitation (ChIP) Sequencing Market

9. China Chromatin immunoprecipitation (ChIP) Sequencing Market

10. India Chromatin immunoprecipitation (ChIP) Sequencing Market

11. Japan Chromatin immunoprecipitation (ChIP) Sequencing Market

12. Australia Chromatin immunoprecipitation (ChIP) Sequencing Market

13. Indonesia Chromatin immunoprecipitation (ChIP) Sequencing Market

14. South Korea Chromatin immunoprecipitation (ChIP) Sequencing Market

15. Western Europe Chromatin immunoprecipitation (ChIP) Sequencing Market

16. UK Chromatin immunoprecipitation (ChIP) Sequencing Market

17. Germany Chromatin immunoprecipitation (ChIP) Sequencing Market

18. France Chromatin immunoprecipitation (ChIP) Sequencing Market

19. Italy Chromatin immunoprecipitation (ChIP) Sequencing Market

20. Spain Chromatin immunoprecipitation (ChIP) Sequencing Market

21. Eastern Europe Chromatin immunoprecipitation (ChIP) Sequencing Market

22. Russia Chromatin immunoprecipitation (ChIP) Sequencing Market

23. North America Chromatin immunoprecipitation (ChIP) Sequencing Market

24. USA Chromatin immunoprecipitation (ChIP) Sequencing Market

25. Canada Chromatin immunoprecipitation (ChIP) Sequencing Market

26. South America Chromatin immunoprecipitation (ChIP) Sequencing Market

27. Brazil Chromatin immunoprecipitation (ChIP) Sequencing Market

28. Middle East Chromatin immunoprecipitation (ChIP) Sequencing Market

29. Africa Chromatin immunoprecipitation (ChIP) Sequencing Market

30. Chromatin immunoprecipitation (ChIP) Sequencing Market Competitive Landscape And Company Profiles

31. Chromatin immunoprecipitation (ChIP) Sequencing Market Other Major And Innovative Companies

32. Global Chromatin immunoprecipitation (ChIP) Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chromatin immunoprecipitation (ChIP) Sequencing Market

34. Recent Developments In The Chromatin immunoprecipitation (ChIP) Sequencing Market

35. Chromatin immunoprecipitation (ChIP) Sequencing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기